Federated Hermes
KYMR icon

Federated Hermes’s Kymera Therapeutics KYMR Stock Holding History

Federated Hermes’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.9M Buy
749,398
+212,718
+40% +$18.3M 0.12% 190
2026
Q1 		$44.7M Sell
536,680
-227,240
-30% -$18M 0.07% 286
2025
Q4 		$59.4M Buy
763,920
+205,220
+37% +$13.9M 0.1% 236
2025
Q3 		$31.6M Buy
+558,700
New +$25.2M 0.06% 348
2025
Q1 		– Sell
-32
Closed -$1.29K – 2130
2024
Q4 		$1.29K Sell
32
-6,702
-100% -$303K ﹤0.01% 2006
2024
Q3 		$319K Buy
6,734
+7
+0.1% +$309 ﹤0.01% 1409
2024
Q2 		$201K Sell
6,727
-39
-0.6% -$1.35K ﹤0.01% 1475
2024
Q1 		$272K Buy
+6,766
New +$242K ﹤0.01% 1438

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Federated Hermes's KYMR Position: Q2 2026 in Review

Federated Hermes increased its Kymera Therapeutics (KYMR) stake by 40% in Q2 2026, buying an estimated $18.3M and bringing the position to 749,398 shares worth $85.9M. The position accounts for 0.12% of the portfolio, ranked #190.

Federated Hermes first reported a position in KYMR in Q1 2024 and has held it in 8 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Federated Hermes held 749,398 shares of Kymera Therapeutics worth $85.9M as of Q2 2026.
  • Federated Hermes bought 212,718 Kymera Therapeutics shares in Q2 2026, an estimated $18.3M.
  • Kymera Therapeutics made up 0.12% of Federated Hermes's portfolio in Q2 2026, its #190 holding.
  • Federated Hermes first reported a position in Kymera Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.